JAMIE MORALES: Open Payments
NPI 1811642176 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 26 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,983 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $161 |
| ABBVIE INC. | 9 | $149 |
| Alexion Pharmaceuticals, Inc. | 1 | $34 |
| Biogen, Inc. | 1 | $22 |
| Medtronic, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| PIRAMAL CRITICAL CARE | 1 | $20 |
| JAZZ PHARMACEUTICALS INC. | 1 | $19 |
| PFIZER INC. | 1 | $19 |
Products named: KESIMPTA, QULIPTA, VYALEV, ULTOMIRIS, BOTOX, VUMERITY, SYNCHROMEDII, UPLIZNA.
Industry payments across MS — which companies pay providers there.
